Hospital Value-based Purchasing

The Centers for Medicare & Medicaid Services yesterday proposed delaying Medicaid “best price” and “best price reporting” requirements for state value-based purchasing agreements with drug manufacturers until July 2022.
Join Mark Kenneday, former ASHE president and Gordian’s director of healthcare market strategy and development, as he explores a new approach that shifts away from the fee-for-service model of health care construction to a value-based model.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups…
Download the Special Bulletin: CMS Releases Proposed Rule on Medicaid Drug Value-based Purchasing Arrangements  
AHA comments on Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update and CY 2019 Case-Mix Adjustment Methodology Refinements; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; Home Infusion Therapy Requirements; and Home…